The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N05 | Psycholeptics | |
| 3 | N05B | Anxiolytics | |
| 4 | N05BA | Benzodiazepine derivatives | |
| 5 | N05BA23 | Tofisopam |
| Active Ingredient | Description | |
|---|---|---|
| Tofisopam |
Tofisopam is an atypical benzodiazepine derivative. It has an anxiolytic effect, almost not-accompanied by a sedative, muscle relaxant, anticonvulsant action. Tofisopam is a psychovegetative regulator, it eliminates various forms of autonomic disorders. It has a mild stimulating activity. Due to the lack miorelaxant effect tofisopam can also be used in patients with myopathy and myasthenia. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
